REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $259,000 | -37.4% | 10,280 | -34.5% | 0.03% | -43.5% |
| Q4 2021 | $414,000 | +77.7% | 15,700 | +579.7% | 0.05% | +64.3% |
| Q3 2021 | $233,000 | -59.1% | 2,310 | -59.6% | 0.03% | -56.2% |
| Q1 2021 | $570,000 | +125.3% | 5,713 | +252.9% | 0.06% | +68.4% |
| Q2 2020 | $253,000 | -28.1% | 1,619 | -6.0% | 0.04% | -32.1% |
| Q4 2019 | $352,000 | +46.1% | 1,722 | -42.6% | 0.06% | +33.3% |
| Q3 2019 | $241,000 | -20.2% | 3,000 | -15.0% | 0.04% | -16.0% |
| Q1 2019 | $302,000 | +39.8% | 3,531 | -64.4% | 0.05% | -13.8% |
| Q4 2016 | $216,000 | – | 9,908 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |